Ontology highlight
ABSTRACT: Rationale & objective
Information regarding disparities in initiating sodium/glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) in patients with chronic kidney disease (CKD) is limited. We examined sociodemographic and clinical factors associated with the initiation of SGLT2i, GLP-1RA, or second-generation sulfonylureas in a Medicare Fee-For-Service patient population with CKD and type 2 diabetes.Study design
Retrospective cohort study.Setting & participants
The 20% random sample of Medicare Fee-For-Service claims, 2012-2018.Exposures
Patients' sociodemographic and clinical factors.Outcomes
Use of SGLT2i, GLP-1RA, or sulfonylureas.Analytical approach
Patients with a newly initiated prescription
SUBMITTER: Zhao JZ
PROVIDER: S-EPMC9803841 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature